Radioactive isotopes produced for medical applications: setting up an accurate measurement method for production cross section - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2018

Radioactive isotopes produced for medical applications: setting up an accurate measurement method for production cross section

Résumé

The nuclear medicine is a medical specialty that uses radionuclides for diagnosis or therapy. Several modalities are used in diagnosis (PET/SPECT, Positron Emission Tomography/Single Photon Emission Computed Tomography) which takes advantage of the photon emissions occurring during the decay of the radionuclide. In therapy, strongly interacting particles obtained through the radioactive decay are used such as alpha, beta or Auger electrons. They are mostly used coupled to a vector molecule for targeted therapy. The trend followed by nuclear medicine is to become more and more personalized to each patient. To reach that goal, a wide variety of radionuclides (different decay particles, different half-lives, different chemical properties) must be available to meet the patient’s need. Their production is achieved using reactor or accelerator and has to be well controlled. In order to optimize the production of radionuclides, a good knowledge of the radionuclide production cross section is required. In collaboration with the GIP ARRONAX[1] which possesses a multi-particle high energy cyclotron, the project is to get an accurate measurement of production cross sections for a wide variety of radionuclides. Among the information requires for a precise measurement, the flux of the incident particle is the more important one. The data about the particle flux of the beam can be evaluated using a monitor reaction with a well-known cross section whose values are recommended by the International Atomic Energy Agency (IAEA). The uncertainty (around 10%) associated to the monitor cross section values results in a high uncertainty on the measured ones. Another method is to measure the amount of charges crossing the stack. This method allows reducing the uncertainty on the measured cross section (<3%). In order to use this technique, a new experimental cross section measurement device has been set up and it is being tested in well-known conditions. Both techniques of flux determination and final cross section data have been used in a well define example: the production of the 197mHg (T1/2 = 23.8h) which emits only low energies gammas emissions, 70-410 keV with main emissions at 134 keV 33% and 279 keV 6%. These features make the 197mHg a great candidate for the SPECT imagery. The results obtained reveal that the new experimental set-up works well and the results are in good agreement with the IAEA recommended cross section values and other available data in the literature. The satisfying results obtained show that this method can be used to measure production cross sections and complete data base for radionuclides of interest.
JED 2018 - NIGRON.pdf (1.22 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02414720 , version 1 (19-12-2019)

Identifiants

  • HAL Id : hal-02414720 , version 1

Citer

Etienne Nigron, Arnaud Guertin, Ferid Haddad. Radioactive isotopes produced for medical applications: setting up an accurate measurement method for production cross section. Journée de l'école doctorale "Matière, Molécules et Matériaux" Rennes 2018, Oct 2018, Rennes, France. ⟨hal-02414720⟩
60 Consultations
14 Téléchargements

Partager

Gmail Facebook X LinkedIn More